Study S000732

Pilot Study of the Effect of Weight Loss by Pharmacotherapy on Chronic Pro-tumor Inflammatory Cells

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05756764
Study type: OBSERVATIONAL
Status: ACTIVE_NOT_RECRUITING
Enrollment: 30
Start: 2023-06-01
Primary completion: 2026-01-30
Lead sponsor: Louisiana State University Health Sciences Center in New Orleans
Conditions: Obesity
Interventions: DRUG:Semaglutide; DRUG:Phentermine-Topiramate combination; DRUG:Phentermine; DRUG:Tirzepatide; DRUG:Topiramate; DRUG:Diethylpropion; DRUG:Naltrexone/Bupropion; DRUG:Liraglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: NIH:U24DK132740

Registered primary outcomes

weight loss [baseline and 24 weeks]
MDSC in peripheral blood [baseline and 24 weeks]
Levels of lipids in circulation [baseline and 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.